Roche’s OneLiver mission

Roche’s OneLiver mission has our diagnostics and pharmaceutical divisions working together to help break the cycle of chronic liver disease (CLD) progressing to hepatocellular carcinoma (HCC).

Our core expertise focuses on cutting-edge diagnostics and treatments. To enable greater impact, partnerships are key. We want to work together with liver specialists, researchers and patient organisations across the disease continuum to improve the outcomes of patients impacted by CLD and HCC.

Find out more:

OneLiver Science Hub

This is a repository of information on CLD and liver cancer, including disease burden, early detection and treatment, and multidisciplinary management.

Combating Cancer - Liver cancer

This is an educational platform that provides Healthcare Professionals with the latest scientific content and thought leadership topics focusing on the value of diagnostics – from screening to diagnosis and management.

To receive updates from Roche click here

__________________________________________________________________

Roche Science Hub/Medically is a single non-promotional source of medical education and scientific information for healthcare professionals. Roche Science Hub/Medically may contain information on medicines or indications that have not been registered by Medsafe. No recommendations regarding safety and efficacy can be made for any unregistered use. Any treatment decisions based on the information provided are the full responsibility of the prescribing physician. Before prescribing a New Zealand registered medicine, please review the Data Sheet at www.medsafe.govt.nz
Roche Products (New Zealand) Ltd, Auckland.
Ph: 0800 656 464. www.roche.co.nz
All trademarks herein are protected by law.
M-NZ-00000924/TAPS-MR10185/MAR2024